Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chow EJ, Mueller BA, Baker KS, Cushing-Haugen KL, Flowers ME, Martin PJ et al. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med 2011; 155: 21–32.

    Article  Google Scholar 

  2. Armenian SH, Sun CL, Vase T, Ness KK, Blum E, Francisco L et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood 2012; 120: 4505–4512.

    Article  CAS  Google Scholar 

  3. Annaloro C, Usardi P, Airaghi L, Giunta V, Forti S, Orsatti A et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 797–804.

    Article  CAS  Google Scholar 

  4. Majhail NS, Flowers ME, Ness KK, Jagasia M, Carpenter PA, Arora M et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2009; 43: 49–54.

    Article  CAS  Google Scholar 

  5. Bassi N, Karagodin I, Wang S, Vassallo P, Priyanath A, Massaro E et al. Lifestyle modification for metabolic syndrome: a systematic review. Am J Med 2014; 127: e1–e10.

    Article  Google Scholar 

  6. Demark-Wahnefried W, Jones LW . Promoting a healthy lifestyle among cancer survivors. Hematol Oncol Clin North Am 2008; 22: 319–342.

    Article  Google Scholar 

  7. Vale MJ, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL et al. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med 2003; 163: 2775–2783.

    Article  Google Scholar 

  8. Jelinek M, Vale MJ, Liew D, Grigg L, Dart A, Hare DL et al. The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-up. Heart Lung Circ 2009; 18: 388–392.

    Article  Google Scholar 

  9. World Health Organization Physical status: the use and interpretation of anthropometry. World Health Organization: Geneva, 1995.

  10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et alHarmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 2009; 120: 1640–1645.

    Article  CAS  Google Scholar 

  11. Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE . The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract 2007; 77: 471–478.

    Article  Google Scholar 

  12. Natarajan P, Ray KK, Cannon CP . High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol 2010; 55: 1283–1299.

    Article  CAS  Google Scholar 

  13. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8–15.

    Article  CAS  Google Scholar 

  14. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999; 341: 410–418.

    Article  CAS  Google Scholar 

  15. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011; 34: 1481–1486.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge the participants of the study as well as the staff of the Late Effects Clinic at The Alfred Hospital, particularly Helen McLauchlan. This project was supported by the Victorian Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Avery.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Viner Smith, E., Tierney, A., Klarica, D. et al. Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation. Bone Marrow Transplant 51, 722–724 (2016). https://doi.org/10.1038/bmt.2015.312

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.312

This article is cited by

Search

Quick links